In non-neuronal cells such as cerebral endothelial cells and platelets, Aβ was found to activate RhoA/ROCK signaling and lead to the disruption of blood-brain barrier and activation of platelets, both of which are associated with AD (Sonkar et al., 2014; Park et al., 2017). This evidence concerns the gene RHOA and Alzheimer disease.